• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL BRASIL LTDA. (NOVA LIMA) EPIC STENTED PORCINE HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL BRASIL LTDA. (NOVA LIMA) EPIC STENTED PORCINE HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number EL-29M
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problems Corneal Pannus (1447); Calcium Deposits/Calcification (1758); Ischemia (1942); Myocardial Infarction (1969); Sepsis (2067); Heart Failure (2206)
Event Date 01/14/2015
Event Type  Injury  
Event Description
In (b)(6) 2005, the patient underwent a mitral valve replacement for rheumatic valve stenosis where this tissue valve was implanted, and a concomitant maze procedure with closure of the left atrial appendage.In 2008, the patient had a thromboembolic infarction of the right coronary artery treated with thrombectomy and coronary artery stenting.In 2010, the patient had an embolic ischemia of the left leg, which was surgically treated.In 2013, the patient was hospitalized with septicemia and per report had normal valve function.In (b)(6) 2015, the patient presented with cardiac failure.Aortic and mitral valve replacement and tricuspid annuloplasty was performed.A larger 31 mm bioprosthesis was implanted in the mitral position.The explanted mitral valve was noted to be heavily calcified with pannus and cuspal tears.The patient was discharged from the hospital post procedure.
 
Manufacturer Narrative
(b)(4).
 
Manufacturer Narrative
(b)(4).The results of this investigation concluded all cusps contained tears, calcifications, and were fibrotically thickened.There was fibrous pannus ingrowth on the inflow surface of all cusps.Special stains were negative for organisms, and no inflammation was present.There was no evidence found to suggest the cause of the fibrin, calcification, pannus, and tears were due to an intrinsic defect in the valve, as supported by review of the valve's device history record and the analysis performed.The cause of the reported event remains unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EPIC STENTED PORCINE HEART VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ST. JUDE MEDICAL BRASIL LTDA. (NOVA LIMA)
caixa postal 106
belo horizonte 3400 0-00
BR  34000-000
Manufacturer (Section G)
ST. JUDE MEDICAL BRASIL LTDA. (NOVA LIMA)
caixa postal 106
belo horizonte 3400 0-00
BR   34000-000
Manufacturer Contact
denise johnson
5050 nathan lane north
plymouth, MN 55442
6517565400
MDR Report Key4516317
MDR Text Key5443264
Report Number3001743903-2015-00010
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeEN
PMA/PMN Number
P040021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/15/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/13/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/08/2008
Device Model NumberEL-29M
Device Catalogue NumberEL-29M
Device Lot Number2976616
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/11/2015
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/15/2015
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/09/2005
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age67 YR
-
-